Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis
Titel:
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis
Auteur:
Bardsley, Samuel Criner, Gerard J. Halpin, David M.G. Han, MeiLan K. Hanania, Nicola A. Hill, David Lange, Peter Lipson, David A. Martinez, Fernando J. Midwinter, Dawn Siler, Thomas M. Singh, Dave Wise, Robert A. van Zyl-Smit, Richard N. Berkman, Neville